Delisting risk
Sonoma Pharmaceuticals
Develops and manufactures shelf-stable hypochlorous-acid products for wound, skin, eye, foot, animal, and surface care.
$1.31
After-hours close−0.01 (−0.76%)
At close$1.32(−0.75%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 4.01%Insiders —
Shares outstanding 1.68M · Float 1.67M · 99.4% free float
Insiders — no current Form 4 position.
Institutions13F, as of Mar 31, 2026
17 holders · 67.5K shares · 5 new positions · 9 increased · 1 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 19.9K | 1.18% | +4.0K | May 15, 2026 |
| Vanguard Capital Management LLC | 18.8K | 1.12% | +18.8Knew | May 15, 2026 |
| DRW Securities, LLC | 12.0K | 0.71% | −49.0K | May 13, 2026 |
| Mckinley Carter Wealth Services, Inc. | 11.2K | 0.66% | 0 | Apr 20, 2026 |
| Morgan Stanley | 2.0K | 0.12% | +2.0K | May 15, 2026 |
| Citigroup Inc | 1.4K | 0.08% | +1.4K | May 11, 2026 |
| Tower Research Capital LLC (TRC) | 1.2K | 0.07% | +846 | May 15, 2026 |
| Advisor Group Holdings, Inc. | 500 | 0.03% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
No current Form 4 position on record.
19 people have not refiled in the last 18 months (22.5K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.